4.8 Article

Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells

期刊

SCIENCE
卷 348, 期 6238, 页码 1031-1035

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aaa4812

关键词

-

资金

  1. National Institutes of Health [DP5OD012116, DK071176]
  2. National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity
  3. Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (from the U.S. National Center for Research Resources) [UL1-RR024134]
  4. Crohn's and Colitis Foundation of America (CCFA) [297365]
  5. Cancer Research Institute Student Training and Research in Tumor immunology (STaRT) grant
  6. Wellcome Trust Research Career Development Fellowship

向作者/读者索取更多资源

Inflammatory CD4(+) T cell responses to self or commensal bacteria underlie the pathogenesis of autoimmunity and inflammatory bowel disease (IBD), respectively. Although selection of self-specific T cells in the thymus limits responses to mammalian tissue antigens, the mechanisms that control selection of commensal bacteria-specific T cells remain poorly understood. Here, we demonstrate that group 3 innate lymphoid cell (ILC3)-intrinsic expression of major histocompatibility complex class II (MHCII) is regulated similarly to thymic epithelial cells and that MHCII+ ILC3s directly induce cell death of activated commensal bacteria-specific T cells. Further, MHCII on colonic ILC3s was reduced in pediatric IBD patients. Collectively, these results define a selection pathway for commensal bacteria-specific CD4(+) T cells in the intestine and suggest that this process is dysregulated in human IBD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据